NORWALK, CT , Feb. 11, 2026 (GLOBE NEWSWIRE) -- HCM IV Acquisition Corp (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset ...

Delhi Police HCM Answer Key 2025-26: The Staff Selection Commission (SSC) will release the provisional answer key for the Delhi Police Head Constable Exam 2026 shortly. The Delhi Police Head Constable ...

Many symptoms of hypertrophic cardiomyopathy (HCM) are mild, particularly in the early stages of the disease, so they may be easy to dismiss. Symptoms such as shortness of breath during exercise, ...

If you or a loved one has recently been diagnosed with hypertrophic cardiomyopathy (HCM), you may have questions about what it means for your health and how to manage the condition. Understanding ...

The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced. Aficamten is an allosteric and reversible inhibitor of ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved aficamten to improve functional capacity and symptoms in adults with obstructive hypertrophic ...

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Myqorzo (aficamten, Cytokinetics) for treating adults ...

At UKG Aspire 2025, UKG announced its Workforce Intelligence Hub, designed to consolidate workforce data across HR, pay, and workforce management, and combine it with external benchmarks and other ...

Most people with HCM can participate in mild- to moderate-intensity exercise safely. When it comes to vigorous exercise and competitive sports, there may be a need for additional guidance from your ...

FPC is known for its expertise in payroll reconstruction, agency notice resolution, Employee Retention Credit (ERC) filings, and merger & acquisition compliance. By integrating FPC’s capabilities, HCM ...

MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...